Background Psoriasis is a chronic, systemic immune‐mediated disease characterized by
development of erythematous, indurated, scaly, pruritic and often painful skin plaques …

Psoriasis is a common inflammatory skin disease characterized by the appearance of red
scaly plaques that can affect any part of the body. High prevalence, chronicity, disfiguration …

This evidence‐and consensus‐based guideline on the treatment of psoriasis vulgaris was
developed following the EuroGuiDerm Guideline and Consensus Statement Development …

This evidence‐and consensus‐based guideline on the treatment of psoriasis vulgaris was
developed following the EuroGuiDerm Guideline and Consensus Statement Development …

Psoriasis is a chronic systemic inflammatory disorder associated with several comorbidities
in addition to the characteristic skin lesions. Metabolic syndrome (MetS) is the most frequent …

Psoriasis is an immune-mediated inflammatory disease, with a chronic relapsing-remitting
course, which affects 2–3% of the worldwide population. The progressive acquisitions of the …

Background Psoriasis is associated with metabolic, liver and cardiovascular comorbidity.
Secukinumab, a fully human monoclonal antibody that selectively neutralizes interleukin …

Psoriasis is a chronic multi-systemic inflammatory disease that affects the epidermal barrier.
Emollients can be used as a coadjutant therapy for psoriasis management, but little is known …

Although oxidative stress is recognized as an important effector mechanism of the immune
system, uncontrolled formation of reactive oxygen and nitrogen species promotes excessive …

Psoriasis is a chronic inflammatory skin disease with a high prevalence of cardiovascular
disease (CVD), obesity, dyslipidemia, hypertension, diabetes mellitus, and metabolic …